Efficacy of tacrolimus in primary kidney transplant patients: multicenter, open-label prospective study

Transplant Proc. 2000 Nov;32(7):1705-8. doi: 10.1016/s0041-1345(00)01406-8.
No abstract available

Publication types

  • Clinical Trial
  • Multicenter Study

MeSH terms

  • ABO Blood-Group System
  • Adult
  • Creatinine / blood
  • Cyclosporine / therapeutic use
  • Diabetes Mellitus / epidemiology
  • Female
  • Graft Rejection / epidemiology*
  • Graft Rejection / physiopathology
  • Graft Rejection / prevention & control
  • Histocompatibility Testing
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use*
  • Incidence
  • Kidney Transplantation / immunology*
  • Kidney Transplantation / physiology
  • Male
  • Middle Aged
  • Postoperative Complications / epidemiology
  • Prevalence
  • Tacrolimus / adverse effects
  • Tacrolimus / therapeutic use*
  • Time Factors

Substances

  • ABO Blood-Group System
  • Immunosuppressive Agents
  • Cyclosporine
  • Creatinine
  • Tacrolimus